Safety, Efficacy, and Long-Term Follow-Up Evaluation of Perioperative Epirubicin, Cisplatin, and Capecitabine Chemotherapy in Esophageal Resection for Adenocarcinoma
- 7 January 2015
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (5) , 1555-1563
Abstract
Perioperative epirubicin, cisplatin, and capecitabine (ECC) chemotherapy was evaluated in patients who underwent esophageal resection for adenocarcinoma of the esophagus or gastroesophageal junction (GEJ).Keywords
This publication has 21 references indexed in Scilit:
- Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancerBritish Journal of Surgery, 2012
- Risk of Thromboembolic Events after Perioperative Chemotherapy Versus Surgery Alone for Esophageal AdenocarcinomaAnnals of Surgical Oncology, 2011
- How to Define a Positive Circumferential Resection Margin in T3 Adenocarcinoma of the EsophagusAmerican Journal of Surgical Pathology, 2011
- Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialEuropean Journal of Cancer, 2011
- A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinomaBritish Journal of Cancer, 2009
- Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric JunctionJournal of Clinical Oncology, 2009
- The Incidence and Risk of Venous Thromboembolism Associated With Cancer and Nonsurgical Cancer TreatmentCancer Investigation, 2009
- Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerNew England Journal of Medicine, 2008
- Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal EsophagusAnnals of Surgery, 2007
- Helicobacter pylori and gastrointestinal tract adenocarcinomasNature Reviews Cancer, 2002